NASDAQ:NRCIB - National Research Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$53.0103 +4.97 (+10.35 %)
(As of 07/16/2018 06:00 AM ET)
Previous Close$53.0103
Today's Range$50.38 - $53.37
52-Week Range$40.27 - $58.16
Volume20,669 shs
Average Volume1,844 shs
Market Capitalization$1.30 billion
P/E Ratio91.40
Dividend Yield5.00%
National Research logoNational Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The company offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. It also provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. The company offers transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction and support safe care transitions; and risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs. It provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems and post-acute providers, such as home health, long term care, hospice, and payer organizations. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.

Receive NRCIB News and Ratings via Email

Sign-up to receive the latest news and ratings for NRCIB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Commercial physical research
Sub-IndustryHealth Care Services
SectorBusiness Services


Debt-to-Equity RatioN/A
Current Ratio1.62
Quick Ratio1.62


Trailing P/E Ratio91.40
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$117.56 million
Price / Sales11.05
Cash Flow$1.1777 per share
Price / Cash45.01
Book Value$3.68 per share
Price / Book14.40


EPS (Most Recent Fiscal Year)N/A
Net Income$22.94 million
Net Margins19.52%
Return on Equity27.45%
Return on Assets19.09%


Outstanding Shares24,510,000
Market Cap$1,299.28

The Truth About Cryptocurrencies

National Research (NASDAQ:NRCIB) Frequently Asked Questions

What is National Research's stock symbol?

National Research trades on the NASDAQ under the ticker symbol "NRCIB."

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research announced a quarterly dividend on Tuesday, February 20th. Investors of record on Friday, March 30th will be given a dividend of $0.60 per share on Friday, April 13th. This represents a $2.40 dividend on an annualized basis and a yield of 4.53%. The ex-dividend date is Wednesday, March 28th. View National Research's Dividend History.

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRCIB) issued its quarterly earnings data on Thursday, May, 4th. The business services provider reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.81 by $0.55. The business services provider had revenue of $30.28 million for the quarter. National Research had a net margin of 19.52% and a return on equity of 27.45%. View National Research's Earnings History.

What is the consensus analysts' recommendation for National Research?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Research in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of National Research's key competitors?

Who are National Research's key executives?

National Research's management team includes the folowing people:
  • Mr. Michael D. Hays, Founder, CEO & Director (Age 63)
  • Mr. Steven D. Jackson, Pres (Age 42)
  • Mr. Kevin R. Karas CPA, Principal Accounting Officer, Sr. VP of Fin., CFO, Treasurer & Sec. (Age 60)
  • Ms. Helen Hrdy, Sr. VP of Client Services

Has National Research been receiving favorable news coverage?

Press coverage about NRCIB stock has trended somewhat positive this week, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. National Research earned a media sentiment score of 0.11 on Accern's scale. They also assigned news coverage about the business services provider an impact score of 45.17 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of National Research?

Shares of NRCIB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is National Research's stock price today?

One share of NRCIB stock can currently be purchased for approximately $53.0103.

How big of a company is National Research?

National Research has a market capitalization of $1.30 billion and generates $117.56 million in revenue each year. National Research employs 458 workers across the globe.

How can I contact National Research?

National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The business services provider can be reached via phone at 402-475-2525.

MarketBeat Community Rating for National Research (NASDAQ NRCIB)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  125 (Vote Outperform)
Underperform Votes:  127 (Vote Underperform)
Total Votes:  252
MarketBeat's community ratings are surveys of what our community members think about National Research and other stocks. Vote "Outperform" if you believe NRCIB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NRCIB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by Staff

Featured Article: Earnings Per Share (EPS)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.